{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:10:01Z","timestamp":1740107401219,"version":"3.37.3"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:00:00Z","timestamp":1700784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:00:00Z","timestamp":1700784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-023-10458-w","type":"journal-article","created":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T15:02:10Z","timestamp":1700838130000},"page":"3032-3033","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["VI-RADS scoring system for predicting 1- to 5-year recurrence of bladder cancer"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2762-6268","authenticated-orcid":false,"given":"Athina C.","family":"Tsili","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,24]]},"reference":[{"key":"10458_CR1","unstructured":"Gontero P, Comp\u00e9rat E, Dominguez Escrig JL et al (2023) EAU guidelines on non-muscle-invasive bladder cancer (TaT1 and CIS). Available via https:\/\/uroweb.org\/guidelines\/non-muscle-invasive-and-metastatic-bladder-cancer. Assessed 06\/10\/2023"},{"key":"10458_CR2","unstructured":"Witjes JA, Bruins HM, Carri\u00f3n A et al (2023) EAU guidelines on muscle-invasive and metastatic bladder cancer. Available via https:\/\/uroweb.org\/guidelines\/muscle-invasive-and-metastatic-bladder-cancer. Assessed 06\/10\/2023"},{"key":"10458_CR3","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.eururo.2018.04.029","volume":"74","author":"V Panebianco","year":"2018","unstructured":"Panebianco V, Narumi Y, Altun E et al (2018) Multiparametric magnetic resonance imaging for bladder cancer: development of VI-RADS (Vesical Imaging-Reporting and Data System). Eur Urol 74:294\u2013306","journal-title":"Eur Urol"},{"key":"10458_CR4","doi-asserted-by":"publisher","first-page":"7209","DOI":"10.1007\/s00330-023-09677-y","volume":"33","author":"V Panebianco","year":"2023","unstructured":"Panebianco V (2023) VI-RADS for the diagnosis and management of urinary bladder cancer. Eur Radiol 33:7209\u20137211","journal-title":"Eur Radiol"},{"key":"10458_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/jmri.27361","volume":"55","author":"V Panebianco","year":"2022","unstructured":"Panebianco V, Pecoraro M, Del Giudice F et al (2022) VI-RADS for bladder cancer: current applications and future developments. J Magn Reson Imaging 55:23\u201336","journal-title":"J Magn Reson Imaging"},{"key":"10458_CR6","doi-asserted-by":"publisher","first-page":"6949","DOI":"10.1007\/s00330-021-07765-5","volume":"31","author":"MI Metwally","year":"2021","unstructured":"Metwally MI, Zeed NA, Hamed EM et al (2021) The validity, reliability, and reviewer acceptance of VI-RADS in assessing muscle invasion by bladder cancer: a multicenter prospective study. Eur Radiol 31:6949\u20136961","journal-title":"Eur Radiol"},{"key":"10458_CR7","doi-asserted-by":"publisher","first-page":"4606","DOI":"10.1007\/s00330-020-06802-z","volume":"30","author":"C Luo","year":"2020","unstructured":"Luo C, Huang B, Wu Y, Chen J, Chen L (2020) Use of Vesical Imaging-Reporting and Data System (VI-RADS) for detecting the muscle invasion of bladder cancer: a diagnostic meta-analysis. Eur Radiol 30:4606\u20134614","journal-title":"Eur Radiol"},{"key":"10458_CR8","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s00261-021-03365-5","volume":"47","author":"M Pecoraro","year":"2022","unstructured":"Pecoraro M, Del Giudice F, Magliocca F et al (2022) Vesical Imaging-Reporting and Data System (VI-RADS) for assessment of response to systemic therapy for bladder cancer: preliminary report. Abdom Radiol (NY) 47:763\u2013770","journal-title":"Abdom Radiol (NY)"},{"key":"10458_CR9","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1007\/s00330-022-09272-7","volume":"33","author":"J Li","year":"2023","unstructured":"Li J, Cao K, Lin H et al (2023) Predicting muscle invasion in bladder cancer by deep learning analysis of MRI: comparison with vesical imaging-reporting and data system. Eur Radiol 33:2699\u20132709","journal-title":"Eur Radiol"},{"key":"10458_CR10","doi-asserted-by":"publisher","unstructured":"Xu X, Huang Y, Liu Y et al (2023) Multiparametric MRIbased VI-RADS: can it predict 1- to 5-year recurrence of bladder cancer?. Eur Radiol. https:\/\/doi.org\/10.1007\/s00330-023-10387-8","DOI":"10.1007\/s00330-023-10387-8"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-023-10458-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-023-10458-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-023-10458-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T18:12:09Z","timestamp":1716574329000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-023-10458-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,24]]},"references-count":10,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["10458"],"URL":"https:\/\/doi.org\/10.1007\/s00330-023-10458-w","relation":{},"ISSN":["1432-1084"],"issn-type":[{"type":"electronic","value":"1432-1084"}],"subject":[],"published":{"date-parts":[[2023,11,24]]},"assertion":[{"value":"9 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The scientific guarantor of this publication is Athina C. Tsili.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was not required.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was not required.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"value":"\u2022 commentary","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}